|
|
Article: InforMedix CEO Highlights Technological Advancements at Phase IV Clinical Trials Conference.
- Article from:
- Business Wire
- Article date:
- January 12, 2004
CopyrightCOPYRIGHT 2004 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health/Medical Writers
BIOWIRE2K
Phase IV Clinical Trials Conference
ROCKVILLE, Md.--(BUSINESS WIRE)--Jan. 12, 2004
InforMedix, Inc. (OTCBB:IFMX) announced today that Bruce A. Kehr, M.D., chairman and CEO of InforMedix, is a featured speaker in a session entitled, "Employing Technology to Enhance Phase IV Procedures," at the Phase IV Clinical Trials Conference in Philadelphia, PA. During this session tomorrow, Dr. Kehr will present his talk entitled, "Patient Compliance Strategies that Enhance Clinical Trials and Post-Market Outcomes." The data will include information on how the Company's Med-eMonitor System(TM) ...